Renal Retention of Microbubbles
Flank pain has been reported with ultrasound (US) contrast agents. The purpose of this study is to determine whether there is retention of ultrasound contrast agents in the renal microcirculation, which has been described in mice.
- Study Focus: Renal Retention of Lipid Microbubbles
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Study of Whether There is Renal Retention of Lipid Microbubble Ultrasound Contrast Agents|
- Renal retention of microbubbles [ Time Frame: 10 min ] [ Designated as safety issue: No ]Video intensity in the renal circulation 10 min after completion of a clinically indicated contrast echocardiography study.
|Study Start Date:||July 2012|
|Study Completion Date:||October 2012|
|Primary Completion Date:||October 2012 (Final data collection date for primary outcome measure)|
Patients undergoing contrast-enhanced echo.
In this study patients undergoing clinically indicated contrast echocardiography will have renal ultrasound performed 10 minutes after completion of contrast infusion to determine the presence and location of renal retention of lipid microbubbles.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01647464
|United States, Oregon|
|Oregon Health & Science University|
|Portland, Oregon, United States, 97239|